Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Storb

Showing results (481-490 of 899) with videos related to

Pageof 90
Sort By:
Blood|August 1, 1988
Use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous marrow transplantation for lymphoid malignanciesJ Nemunaitis, J W Singer, C D Buckner, et al.
Transplantation Proceedings|March 1, 1979
The detection of non-HLA antibodies and their possible role in bone marrow graft rejectionF H Claas, J J van Rood, R P Warren, et al.
American Journal of Clinical Pathology|August 1, 1974
Transplantation of bone marrow in refractory marrow failure and neoplastic diseasesR Storb, E D Thomas, C D Buckner, et al.
Hematological Oncology|April 1, 1984
Phenotyping of canine lymphoma with monoclonal antibodies directed at cell surface antigens: classification, morphology, clinical presentation and response to chemotherapyF R Appelbaum, G E Sale, R Storb, et al.
Blood|October 1, 1978
Erythropoiesis in vitro: effect of normal versus "transfusion-sensitized" mononuclear cellsB J Torok-Storb, R Storb, T C Graham, et al.
Blood|September 1, 1996
Failure of recombinant stem cell factor to enhance engraftment of L-leucyl-L-leucine methyl ester treated canine marrow after irradiationH P Kiem, W Leisenring, R Raff, et al.
Annals of Internal Medicine|August 1, 1984
Long-term survival after marrow transplantation for paroxysmal nocturnal hemoglobinuria with aplastic anemiaJ Szer, H J Deeg, R P Witherspoon, et al.
Blood|June 1, 1995
Use of a water-soluble busulfan formulation--pharmacokinetic studies in a canine modelG Ehninger, U Schuler, U Renner, et al.
Transplantation Proceedings|December 1, 1984
Ineffective cellular interaction and interleukin 2 deficiency causing T cell defects in human allogeneic marrow recipients early after grafting and in those with chronic graft-versus-host diseaseM S Tsoi, T Mori, S Brkic, et al.
Experimental Hematology|September 1, 1984
Secondary malignancies after marrow transplantationH J Deeg, J Sanders, P Martin, et al.
Pageof 90

Showing results (481-490 of 899) with videos related to

Sort By:
Pageof 90
Blood|August 1, 1988
Use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous marrow transplantation for lymphoid malignanciesJ Nemunaitis, J W Singer, C D Buckner, et al.
Transplantation Proceedings|March 1, 1979
The detection of non-HLA antibodies and their possible role in bone marrow graft rejectionF H Claas, J J van Rood, R P Warren, et al.
American Journal of Clinical Pathology|August 1, 1974
Transplantation of bone marrow in refractory marrow failure and neoplastic diseasesR Storb, E D Thomas, C D Buckner, et al.
Hematological Oncology|April 1, 1984
Phenotyping of canine lymphoma with monoclonal antibodies directed at cell surface antigens: classification, morphology, clinical presentation and response to chemotherapyF R Appelbaum, G E Sale, R Storb, et al.
Blood|October 1, 1978
Erythropoiesis in vitro: effect of normal versus "transfusion-sensitized" mononuclear cellsB J Torok-Storb, R Storb, T C Graham, et al.
Blood|September 1, 1996
Failure of recombinant stem cell factor to enhance engraftment of L-leucyl-L-leucine methyl ester treated canine marrow after irradiationH P Kiem, W Leisenring, R Raff, et al.
Annals of Internal Medicine|August 1, 1984
Long-term survival after marrow transplantation for paroxysmal nocturnal hemoglobinuria with aplastic anemiaJ Szer, H J Deeg, R P Witherspoon, et al.
Blood|June 1, 1995
Use of a water-soluble busulfan formulation--pharmacokinetic studies in a canine modelG Ehninger, U Schuler, U Renner, et al.
Transplantation Proceedings|December 1, 1984
Ineffective cellular interaction and interleukin 2 deficiency causing T cell defects in human allogeneic marrow recipients early after grafting and in those with chronic graft-versus-host diseaseM S Tsoi, T Mori, S Brkic, et al.
Experimental Hematology|September 1, 1984
Secondary malignancies after marrow transplantationH J Deeg, J Sanders, P Martin, et al.
Pageof 90